Home > Food & Beverages > Nutraceuticals > Fertility Supplements Market

Fertility Supplements Market Trends

Report ID: GMI7083
Published Date: Oct 2023
Report Format: PDF

Download Free Sample

Fertility Supplements Market Trends

The fertility supplement industry is still expanding, because of a mix of demographic factors, such as delayed parenthood and a growing awareness of reproductive concerns. Customers are increasingly looking for fertility supplements that take a holistic approach to reproductive health, focusing not just on improving conception but also on general well-being. As a result, there is a growing demand for products that are evidence-based, scientifically made, and contain a combination of antioxidants, minerals, vitamins, and herbal compounds.

Authors: Kiran Pulidindi, Manish Mohanan

Frequently Asked Questions (FAQ) :

The market size of fertility supplement reached USD 1.9 billion in 2022 and is set to cross USD 4.4 billion by the end of 2032, says this GMI report.

Capsules segment held a dominant market share of over 40% in 2022, as they eliminate the need for measurement and mixing, making them a simple and hassle-free solution for people looking to improve their fertility.

North America market revenue was valued at USD 0.67 billion in 2022, as infertility is becoming more common in the region because of factors such as delayed childbirth, lifestyle changes, and environmental contaminants.

Fairhaven Health, Coast Science, Lenus Pharma GesmbH, Active Bio Life Science GmbH, Orthomol, Exeltis USA, Inc., PregPrep LLC, MegaFood, Theralogix, Fertility Nutraceuticals LLC, Vitabiotics Ltd, Zenith Nutrition, GNC Holdings, Nutraceutical Corporation, and Proxeed.